Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

125%

5 of 4 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

Phase 2

3(60.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

5Total

Phase 2(3)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT01225055Phase 2Completed

Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

Role: lead

NCT00844480Phase 2Terminated

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss

Role: lead

NCT00125528Phase 2Completed

D-cycloserine in the Management of Chronic Low Back Pain

Role: lead

NCT01654302Phase 1Completed

Efficacy and Safety of Synera in Osteoarthritis Pain

Role: lead

NCT00826228Phase 4Completed

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

Role: lead

All 5 trials loaded